Healthcare

Private Practices Are Being Squeezed by Med Spas and Hospital Systems, Dr. Meegan Gruber Warns Patients Must Put Safety First

Med spas together with hospital systems have started compressing private practices; Dr. Meegan Gruber urges patients to prioritize safety. TAMPA,…

5 months ago

Private Practices Are Being Squeezed by Med Spas and Hospital Systems, Dr. Meegan Gruber Warns Patients Must Put Safety First

Med spas together with hospital systems have started compressing private practices; Dr. Meegan Gruber urges patients to prioritize safety. TAMPA,…

5 months ago

San Diego Charity Golf Tournament at Maderas Golf Club to Support Veterans, First Responders and NUCCA Awareness

Dr. Vivek Soham and the Origin Vitae Network Host the Guardian Classic Charity Golf Tournament on Sept. 8, 2025 SAN…

5 months ago

San Diego Charity Golf Tournament at Maderas Golf Club to Support Veterans, First Responders and NUCCA Awareness

Dr. Vivek Soham and the Origin Vitae Network Host the Guardian Classic Charity Golf Tournament on Sept. 8, 2025 SAN…

5 months ago

neurocare CEO Set to Serve a Further 5 Years as Company Marks 10 Years of Innovation and Impact

Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact. MUNICH, DE / ACCESS Newswire…

5 months ago

neurocare CEO Set to Serve a Further 5 Years as Company Marks 10 Years of Innovation and Impact

Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact. MUNICH, DE / ACCESS Newswire…

5 months ago

Black Book: Global Healthcare Cloud Adoption Surges Toward Enterprise Scale

Black Book's 18-country survey reveals 74% of health systems advancing large-scale rollouts by 2027, fueled by interoperability, AI readiness, and…

5 months ago

Black Book: Global Healthcare Cloud Adoption Surges Toward Enterprise Scale

Black Book's 18-country survey reveals 74% of health systems advancing large-scale rollouts by 2027, fueled by interoperability, AI readiness, and…

5 months ago

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer

Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.Engineered for precision T-cell activation…

5 months ago

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer

Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.Engineered for precision T-cell activation…

5 months ago